On National Prescription Drug Take Back Day, HHS Secretary Robert F. Kennedy Jr. is urging Americans to dispose of their prescription medications safely.

Diagnosed with an aggressive form of breast cancer at 29, Breanna Bortner found strength and comfort in her dog Mochi, who exhibited signs of awareness and remained by her side during treatment.

We asked brain health experts to share the red flags you shouldn't ignore.

Researchers from University of California San Diego have linked a bacterial toxin called colibactin to the increase in early-onset cases of colorectal cancer.

"For physical and mental balance, chakras must act in concert with one another," writes yoga educator Tony Sanchez.

Poor posture is likely damaging your back, warns Dr. Arthur Jenkins, a spinal surgeon in New York. He explains how it happens and how to prevent chronic back pain.

Lauren Bannon, a North Carolina mother, says ChatGPT saved her life by flagging her medical condition after doctors missed it. She shares how the AI chatbot led to her cancer diagnosis.

West Virginia has launched a "Mountaineer Mile" in an effort to get Americans outside and moving to increase physical and mental health. The state has been a leader in pushing for MAHA initiatives.

Health researchers caution that Bisphenol S (BPS), an endocrine disruptor present in paper receipts, can rapidly absorb into the skin, leading to a notice of violation against major U.S. retailers.

A word-for-word guide to setting limits as a grownup—without the guilt.

Doctors discuss the prevalence, risks and treatments of metastatic melanoma, as Teddi Mellencamp reveals the latest updates in her battle with the deadly disease.

The Fox News Health Newsletter brings you trending and important stories about health care, drug developments, mental health issues, real people's triumphs over medical struggles, and more.

Preliminary data from The Ohio State University has found that dancing the Argentine tango can help reduce chemotherapy-induced neuropathy symptoms, like burning and tingling.

A new study reveals blood tests can predict melanoma recurrence by detecting circulating tumor DNA. Research shows 80% of stage 3 melanoma patients with positive tests experience a return of cancer.